THE ROLE OF ANTI-INFLAMMATORY DRUGS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
▪ Abstract Risk factor intervention is a useful strategy for prevention of poorly understood diseases. Fifteen studies have examined the relation of glucocorticoid and nonsteroid antiinflammatory treatments and onset or progression of Alzheimer's disease (AD). Fourteen of these studies suggest that such treatments (especially nonsteroidal agents) prevent or ameliorate symptoms of AD. Abundant circumstantial evidence implicates inflammation in the pathogenesis of AD. Inhibition of cyclooxygenases, the central action of nonsteroidal antiinflammatory drugs (but not a prominent effect of steroids), limits inflammation, but it may also alter neural metabolic pathways, resulting in cell death from excitotoxicity or oxidative stress. Randomized controlled trials are needed to determine whether steroids, nonsteroidal antiinflammatory drugs, or both can prevent or treat the symptoms of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · cited 4×
“There is evidence of elevated activity in AD of cytokines such as interleukin-1 β (IL-1β) (47), IL-6 (48, 49), and tumor necrosis factor (50).”
InfluentialInfluence of education and occupation on the incidence of Alzheimer's disease
Stern, Y. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370056032 · Cited by 1,434
Biochemistry of Lipids, Lipoproteins and Membranes
(2021) · Elsevier eBooks · doi:10.1016/c2020-0-00089-7 · Cited by 1,400
Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225
Zhang, M., Katzman, R., Salmon, D., Jin, H., Cai, G., Wang, Z., Qu, G., Grant, I., Yu, E., Levy, P., et al. (1990) · Annals of Neurology · doi:10.1002/ana.410270412 · Cited by 1,047
Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,029
Clinical trial of indomethacin in Alzheimer's disease
Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1609 · Cited by 999
Abraham, C. R., Selkoe, D. J., & Potter, H. (1988) · Cell · doi:10.1016/0092-8674(88)90462-x · Cited by 900
Satz, P. (1993) · Neuropsychology · doi:10.1037//0894-4105.7.3.273 · Cited by 850
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.
O'Banion, M. K., Winn, V. D., & Young, D. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4888 · Cited by 821
Continuous c-fos expression precedes programmed cell death in vivo
Smeyne, R. J., Vendrell, M., Hayward, M., Baker, S. J., Miao, G. G., Schilling, K., Robertson, L. M., Curran, T., & Morgan, J. I. (1993) · Nature · doi:10.1038/363166a0 · Cited by 775
Vane, J. (1994) · Nature · doi:10.1038/367215a0 · Cited by 699
β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
Koh, J.-Y., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617
Mechanisms Underlying Long-Term Potentiation of Synaptic Transmission
Madison, D. V., Malenka, R. C., & Nicoll, R. A. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.002115 · Cited by 617
Production of superoxide anions by a CNS macrophage, the microglia
Colton, C. A., & Gilbert, D. L. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80305-8 · Cited by 614
Prostaglandin endoperoxide synthase: structure and catalysis
Smith, W. L., & Marnett, L. J. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90119-3 · Cited by 601
Microglia in degenerative neurological disease
McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., & McGeer, E. G. (1993) · Glia · doi:10.1002/glia.440070114 · Cited by 596
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.
Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., Donnelly, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7606 · Cited by 595
Mortimer, J. A., Van Duijn, C. M., Chandra, V, Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Rocca, W. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s28 · Cited by 594
Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M.-X., Ginsberg, H., Chun, M., Tycko, B., & Shelanski, M. (1995) · Neurology · doi:10.1212/wnl.45.3.555 · Cited by 590
Roberts, G. W., Gentleman, S. M., Lynch, A., Murray, L., Landon, M., & Graham, D. I. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.419 · Cited by 569
Breitner, J. C. S., Gau, B. A., Welsh, K. A., Plassman, B. L., McDonald, W. M., Helms, M. J., & Anthony, J. C. (1994) · Neurology · doi:10.1212/wnl.44.2.227 · Cited by 568
Alzheimer's disease: A study of epidemiological aspects
Heyman, A., Wilkinson, W. E., Stafford, J. A., Helms, M. J., Sigmon, A. H., & Weinberg, T. (1984) · Annals of Neurology · doi:10.1002/ana.410150406 · Cited by 525
Inflammation and the mechanism of action of anti‐inflammatory drugs
Vane, J., & Botting, R. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.2.3111928 · Cited by 524
Elevated circulating tumor necrosis factor levels in Alzheimer's disease
Fillit, H., Ding, W., Buee, L., Kalman, J., Altstiel, L., Lawlor, B., & Wolf-Klein, G. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90490-k · Cited by 512
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
Breitner, J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00049-k · Cited by 466
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 459
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease
Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., & Brandt, J. (1995) · Neurology · doi:10.1212/wnl.45.1.51 · Cited by 446
A case‐control study of Alzheimer's disease in Australia
Broe, G. A., Henderson, A. S., Creasey, H., McCusker, E., Korten, A. E., Jorm, A. F., Longley, W., & Anthony, J. C. (1990) · Neurology · doi:10.1212/wnl.40.11.1698 · Cited by 445
Anti-inflammatory drugs and Alzheimer disease
Mcgeer, P., Mcgeer, E., Rogers, J., & Sibley, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91101-f · Cited by 437
Strittmatter, W. J., Weisgraber, K. H., Goedert, M., Saunders, A. M., Huang, D., Corder, E. H., Dong, L.-M., Jakes, R., Alberts, M. J., Gilbert, J. R., et al. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1019 · Cited by 433
Nonsteroidal Anti-inflammatory Drugs and Peptic Ulcer Disease
Soll, A. H., Weinstein, W. M., Kurata, J., & McCarthy, D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-4-307 · Cited by 396
Epidemiology of Alzheimer's Disease
Breteler, M. M. B., Claus, J. J., van Duijn, C. M., Launer, L. J., & Hofman, A. (1992) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036092 · Cited by 331
Inflammatory mechanisms in Alzheimer's disease: implications for therapy
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1105 · Cited by 326
Reactive glia as rivals in regulating neuronal survival
Giulian, D. (1993) · Glia · doi:10.1002/glia.440070116 · Cited by 296
The Canadian Study of Health and Aging *: Risk factors for Alzheimer's disease in Canada
Aging, T. C. S. O. H. A. (1994) · Neurology · doi:10.1212/wnl.44.11.2073 · Cited by 295
Complement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemuller, J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
Andersen, K., Launer, L. J., Ott, A., Hoes, A. W., Breteler, M. M. B., & Hofman, A. (1995) · Neurology · doi:10.1212/wnl.45.8.1441 · Cited by 285
Lerea, L. S., & McNamara, J. O. (1993) · Neuron · doi:10.1016/0896-6273(93)90239-n · Cited by 284
Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior
Apter, A., Plutchik, R., & van Praag, H. M. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03321.x · Cited by 264
THE ASSOCIATION BETWEEN HEAD TRAUMA AND ALZHEIMER'S DISEASE
GRAVES, A. B., WHITE, E., KOEPSELL, T. D., REIFLER, B. V., VAN BELLE, G., LARSON, E. B., & RASKIND, M. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115523 · Cited by 257
Complement and cytokine gene expression in cultured microglia derived from postmortem human brains
Walker, D. G., Kim, S. U., & McGeer, P. L. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400407 · Cited by 248
A case‐control study of Alzheimer's disease
Graves, A. B., White, E., Koepsell, T. D., Reifler, B. V., Van Belle, G., Larson, E. B., & Raskind, M. (1990) · Annals of Neurology · doi:10.1002/ana.410280607 · Cited by 237
Jorm, A. F., Van Duijn, C. M., Chandra, V, Fratiglioni, L., Graves, A. B., Heyman, A., Kokmen, E., Kondo, K., Mortimer, J. A., Rocca, W. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s43 · Cited by 237
Mayeux, R., Ottman, R., Tang, M., Noboa‐Bauza, L., Marder, K., Gurland, B., & Stern, Y. (1993) · Annals of Neurology · doi:10.1002/ana.410330513 · Cited by 221
Inducible nitric oxide synthase activity of cloned murine microglial cells
Corradin, S. B., Mauël, J., Donini, S. D., Quattrocchi, E., & Ricciardi‐Castagnoli, P. (1993) · Glia · doi:10.1002/glia.440070309 · Cited by 215
Breteler, M. M. B., Van Duijn, C. M., Chandra, V, Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Mortimer, J. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s36 · Cited by 181
Rozemuller, J. M., Eikelenboom, P., Pals, S. T., & Stam, F. C. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90547-8 · Cited by 173
Neuroimmune Mechanisms in Alzheimer Disease Pathogenesis
McGeer, P. L., Rogers, J., & McGeer, E. G. (1994) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199408030-00001 · Cited by 155
Wagstaff, A. J., & McTavish, D. (1994) · Drugs & Aging · doi:10.2165/00002512-199404060-00006 · Cited by 147
Haga, S., Ikeda, K., Sato, M., & Ishii, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)91698-r · Cited by 145
Rheumatold Arthritis and Senile Dementia of the Alzhelmer's Type
JENKINSON, M. L., BLISS, M. R., BRAIN, A. T., & SCOTT, D. L. (1989) · Rheumatology · doi:10.1093/rheumatology/28.1.86-b · Cited by 143
Relation of Smoking and Alcohol Consumption to Incident Alzheimer's Disease
Hebert, L. E., Scherr, P. A., Beckett, L. A., Funkenstein, H. H., Albert, M. S., Chown, M. J., & Evans, D. A. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116296 · Cited by 129
Head Trauma and the Risk of Alzheimer's Disease
van Duijn, C. M., Tanja, T. A., Haaxma, R., Schulte, W., Saan, R. J., Lameris, A. J., AntonkJes-Hendriks, G., & Hofman, A. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116364 · Cited by 111
The participation of interleukin-6 in the pathogenesis of alzheimer's disease
Bauer, J., Ganter, U., Strauss, S., Stadtmüller, G., Frommberger, U., Bauer, H. C., Volk, B., & Berger, T. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80051-l · Cited by 110
A case‐control study of Alzheimer's disease in China
Li, G., Shen, Y. C., Li, Y. T., Chen, C. H., Zhau, Y. W., & Silverman, J. M. (1992) · Neurology · doi:10.1212/wnl.42.8.1481 · Cited by 104
McGeer, P. L., Harada, N., Kimura, H., McGeer, E. G., & Schulzer, M. (1992) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107010 · Cited by 103
The Age at Onset of Alzheimer's Disease and an Intracranial Area Measurement: A Relationship
Schofield, P. W. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250103019 · Cited by 99
Cytokines in Alzheimer's disease
Altstiel, L. D., & Sperber, K. E. (1991) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(91)90023-t · Cited by 99
Rozemüller, A. J. M., Stam, F. C., & Eikelenboom, P. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90759-3 · Cited by 98
Alzheimer's Disease and Rheumatoid Arthritis
MYLLYKANGAS-LUOSUJÄRVI, R., & ISOMÄKI, H. (1994) · Rheumatology · doi:10.1093/rheumatology/33.5.501 · Cited by 82
Roses, A. D. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80098-5 · Cited by 82
Nonsteroidal antiinflammatory drug use in Alzheimer's disease
Lucca, U., Tettamanti, M., Forloni, G., & Spagnoli, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90598-3 · Cited by 75
Henderson, A. S., Jorm, A. F., Korten, A. E., Creasey, H., McCusker, E., Broe, G. A., Longley, W., & Anthony, J. C. (1992) · Psychological Medicine · doi:10.1017/s0033291700030373 · Cited by 68
Beta-amyloid Formation as a Potential Therapeutic Target for Alzheimer's Disease
Cordell, B. (1994) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.000441 · Cited by 66
Clinical Genetics and Genetic Counseling in Alzheimer Disease
Breitner, J. C. S. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-601 · Cited by 64
Chui, D., Tabira, T., Izumi, S., Koya, G., & Ogata, J. (1994) · PubMed Central · Cited by 63
Lieberburg, I. M., Spinner, N. B., Snyder, S. E., Anderson, J., Goldgaber, D., Smulowitz, M., Carroll, Z., Emanuel, B. S., Breitner, J. C. S., & Rubin, L. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2463 · Cited by 62
Holstein, J., Chatellier, G., Piette, F., & Moulias, R. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06590.x · Cited by 57
Durwen, H. F., & Elger, C. E. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04066.x · Cited by 49
Epidemiology of Alzheimer's disease. Issues of etiology and validity.
Fratiglioni, L. (1993) · PubMed · Cited by 41
Full Complement Activation Fails in Diffuse Plaques of the Alzheimer's Disease Cerebellum
Lue, L., & Rogers, J. (1992) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107031 · Cited by 33
New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause
Breitner, J. C. S. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90199-6 · Cited by 10
(1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb00001.x · Cited by 10
Cited by
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Innate immunity in Alzheimer's disease
Heneka, M. T., Golenbock, D. T., & Latz, E. (2015) · Nature Immunology · doi:10.1038/ni.3102 · Cited by 902
Metadata
- Authors
- Breitner, M. D.
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 1996-02
- Volume
- 47
- Issue
- 1
- Pages
- 401-411
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2148152028
- Cited by
- 263
- References
- 76
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.